WilliamCPierceMD

PubMed

• 5 citations
  The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma.
  Günther G. Steger, Michael Gnant, M.P. Djavanmard, Robert M. Mader, Raimund Jakesz, William Pierce, Jean B. deKernion, Robert A. Figlin, Arie S. Belldegrun> ;Journal of Cancer Research and Clinical Oncology. 1997 Jan 1
• 20 citations
  Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-b...
  Arie S. Belldegrun, Cho-Lea Tso, Randhir Kaboo, Shen Pang, William Pierce, Jean B. deKernion, Robert A. Figlin> ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1996 Mar 1
• 29 citations
  Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment
  Samir Taneja, William Pierce, Robert A. Figlin, Arie S. Belldegrun> ;Urology. 1995 Jun 1
• 11 citations
  Management of disseminated kidney cancer
  Samir Taneja, William Pierce, Robert A. Figlin, Arie S. Belldegrun> ;The Urologic Clinics of North America. 1994 Nov 1
• 48 citations
  Interferon-α Primed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon-α as Therapy for Metastatic Renal Cell Carcinoma
  Arie S. Belldegrun, William Pierce, Randhir Kaboo, Cho-Lea Tso, Hungyi Shau, Patricia Turcillo, Nancy Moldawer, Sidney H. Golub, Jean B. deKernion, Robert A. Figlin> ;The Journal of Urology. 1993 Nov 1
• 11 citations
  Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy.
  Arie S. Belldegrun, William Pierce, David Sayah, Jean B. deKernion, David Wallach, Dan Aderka, Robert A. Figlin> ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1993 Apr 1
• 37 citations
  Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection.
  Faye A. Eggerding, William Pierce> ;Virology. 1986 Jan 15
• 13 citations
  Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
  Robert A. Figlin, William Pierce, Arie S. Belldegrun> ;Seminars in Oncology. 1993 Dec 1
• 16 citations
  Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor...
  Günther G. Steger, William Pierce, Robert A. Figlin, Johannes Czernin, Randhie Kaboo, Jean B. deKernion, Thomas Okarma, Arie S. Belldegrun> ;Clinical Immunology and Immunopathology. 1994 Aug 1
• 27 citations
  Cellular therapy : scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma
  William Pierce, Arie S. Belldegrun, Robert A. Figlin> ;Seminars in Oncology. 1995 Feb 1
• Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.
  Figlin, R. A., Pierce, W. C., Kaboo, R., Tso, C. L., Moldawer, N., Gitlitz, B., deKernion, J., Belldegrun, A.> ;J Urol. 1997 Sep
• 24 citations
  Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors
  John E. Janik, William H. Sharfman, John W. Smitht, Dan L. Longo, Mario Sznol, Walter J. Urba, Robert Figlin, William C. Pierce, Ronald M. Bukowski, Gwen Fyfe, Arie Be...> ;Cancer. 1993 Nov 1
• 1 citations
  Primary tumors of the lung other than lung cancer.
  William Pierce, Robert A. Figlin> ;Current Opinion in Oncology. 1993 Mar 1
• Join now to see all